| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |